Cannabidiol for Inflammatory Bowel Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Crohn's DiseaseUlcerative Colitis
Interventions
DRUG

cannabidiol

cannabidiol given in olive oil drops, 5 mg twice daily

DRUG

placebo in drops

olive oil containing no drug given in drops twice daily

Trial Locations (1)

44281

Sapir Medical center Meir Hospital, Kfar Saba

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER

NCT01037322 - Cannabidiol for Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter